CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 58 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2021$211,0000.0%94,996
+11.8%
0.00%
Q4 2020$211,000
+1.0%
84,9370.0%0.00%
Q3 2020$209,000
-30.8%
84,9370.0%0.00%
Q2 2020$302,000
+153.8%
84,937
+40.6%
0.00%
Q1 2019$119,000
+48.8%
60,4000.0%0.00%
Q4 2018$80,000
-46.3%
60,4000.0%0.00%
Q3 2018$149,000
-12.4%
60,400
+19.8%
0.00%
Q2 2018$170,000
-20.6%
50,4000.0%0.00%
Q1 2018$214,000
+28.1%
50,4000.0%0.00%
Q4 2017$167,000
-13.5%
50,4000.0%0.00%
Q3 2017$193,000
-13.1%
50,4000.0%0.00%
Q2 2017$222,00050,4000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders